Sanofi ADR Ownership
| SNY Stock | USD 48.32 0.33 0.68% |
Shares in Circulation | First Issued 2002-06-30 | Previous Quarter 2.5 B | Current Value 2.5 B | Avarage Shares Outstanding 2.4 B | Quarterly Volatility 380.5 M |
Sanofi Stock Ownership Analysis
The company has price-to-book ratio of 1.35. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sanofi ADR has Price/Earnings To Growth (PEG) ratio of 0.77. The entity last dividend was issued on the 9th of May 2025. The firm had 5:1 split on the 30th of September 2013. Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. Sanofi was founded in 1973 and is headquartered in Paris, France. Sanofi-Aventis operates under Drug ManufacturersGeneral classification in the United States and is traded on NASDAQ Exchange. It employs 95442 people. To find out more about Sanofi ADR contact Paul Hudson at 33 1 53 77 40 00 or learn more at https://www.sanofi.com.Besides selling stocks to institutional investors, Sanofi ADR also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Sanofi ADR's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Sanofi ADR's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Sanofi ADR Quarterly Liabilities And Stockholders Equity |
|
Sanofi Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Sanofi ADR is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sanofi ADR backward and forwards among themselves. Sanofi ADR's institutional investor refers to the entity that pools money to purchase Sanofi ADR's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Boston Partners Global Investors, Inc | 2025-03-31 | 4.1 M | Federated Hermes Inc | 2025-03-31 | 3.9 M | Franklin Resources Inc | 2025-03-31 | 3.9 M | Nuveen Asset Management, Llc | 2024-12-31 | 3.7 M | Mondrian Investment Partners Ltd | 2025-03-31 | 3.4 M | Envestnet Asset Management Inc | 2025-03-31 | 3.3 M | Nuveen, Llc | 2025-03-31 | 3.2 M | Wells Fargo & Co | 2025-03-31 | 3 M | Natixis Advisors, Llc. | 2025-03-31 | 2.9 M | Dodge & Cox | 2025-03-31 | 73.2 M | Fisher Asset Management, Llc | 2025-03-31 | 13.6 M |
Sanofi ADR's latest congressional trading
Congressional trading in companies like Sanofi ADR, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Sanofi ADR by those in governmental positions are based on the same information available to the general public.
| 2019-01-02 | Representative John Rutherford | Acquired Under $15K | Verify |
Sanofi ADR Outstanding Bonds
Sanofi ADR issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Sanofi ADR uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Sanofi bonds can be classified according to their maturity, which is the date when Sanofi ADR has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| SANOFI S A Corp BondUS801060AD60 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Sanofi ADR Corporate Filings
6K | 18th of July 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
| 17th of July 2025 Other Reports | ViewVerify | |
| 27th of June 2025 Other Reports | ViewVerify | |
| 17th of June 2025 Other Reports | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Sanofi Stock Analysis
When running Sanofi ADR's price analysis, check to measure Sanofi ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi ADR is operating at the current time. Most of Sanofi ADR's value examination focuses on studying past and present price action to predict the probability of Sanofi ADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi ADR's price. Additionally, you may evaluate how the addition of Sanofi ADR to your portfolios can decrease your overall portfolio volatility.